docetaxel anhydrous has been researched along with hydroxyurea in 8 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (hydroxyurea) | Trials (hydroxyurea) | Recent Studies (post-2010) (hydroxyurea) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 8,969 | 741 | 2,156 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Denoulet, P; Desbruyères, E; Eddé, B; Regnard, C | 1 |
| Remlinger, KA | 1 |
| Blair, EA; Cohen, EE; Dekker, A; Haraf, DJ; Mauer, A; Seiwert, TY; Stenson, K; Vokes, EE | 1 |
| Agulnik, MB; Braegas, B; Brockstein, BE; Cohen, EE; Egan, R; Haraf, DJ; Huang, CH; Karrison, TG; Kocherginsky, M; Kumar, P; Marchand, P; Mehra, R; Mittal, BB; Mueller, J; Ondrey, F; Raez, LE; Samant, S; Seiwert, TY; Villaflor, VM; Vokes, EE; Yunus, F | 1 |
| Bacchus, ID; Mittal, BB; Refaat, T; Sachdev, S; Sathiaseelan, V | 1 |
| Chang, CL; Chen, JH; Chen, TM; Lai, MT; Lee, FP; Lin, KC; Wu, CC; Wu, SY; Yen, YC; Yuan, KS | 1 |
2 review(s) available for docetaxel anhydrous and hydroxyurea
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cutaneous reactions to chemotherapy drugs: the art of consultation.
Topics: Animals; Antineoplastic Agents; Bleomycin; Docetaxel; Doxorubicin; Drug Eruptions; Humans; Hydroxyurea; Paclitaxel; Skin; Taxoids; Thalidomide | 2003 |
2 trial(s) available for docetaxel anhydrous and hydroxyurea
| Article | Year |
|---|---|
A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Male; Maximum Tolerated Dose; Middle Aged; Survival Analysis; Taxoids | 2007 |
Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Induction Chemotherapy; Male; Middle Aged; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Taxoids | 2014 |
4 other study(ies) available for docetaxel anhydrous and hydroxyurea
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Tubulin polyglutamylase: isozymic variants and regulation during the cell cycle in HeLa cells.
Topics: Animals; Brain; Cell Cycle; Cell Division; Centrioles; Docetaxel; G2 Phase; Gene Expression Regulation, Enzymologic; Genetic Variation; HeLa Cells; Humans; Hydroxyurea; Isoenzymes; Mice; Nocodazole; Paclitaxel; Peptide Synthases; Polyglutamic Acid; Spindle Apparatus; Taxoids; Tubulin | 1999 |
Age most significant predictor of requiring enteral feeding in head-and-neck cancer patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Docetaxel; Enteral Nutrition; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hydroxyurea; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Taxoids | 2015 |
Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Deoxycytidine; Docetaxel; Female; Fluorouracil; Gemcitabine; Head and Neck Neoplasms; Humans; Hydroxyurea; Male; Methotrexate; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Paclitaxel; Prognosis; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Taxoids; Treatment Outcome; Young Adult | 2017 |